GlobeNewswire

VIVUS Announces Positive Outcome of European Procedure to Extend QSIVA® (Phentermine/Topiramate MR) to Adolescents with Obesity
19/10/2026
— Landmark European approval will grant young patients and families an evidence-based therapy alongside lifestyle interventions AMSTERDAM, Oct. 19, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a [...]
RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation
19/10/2026
ALISO VIEJO, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced the appointments of Taryn Conway as Chief Commercial Officer and Frank Shields as Executive Vice President of Sales and [...]
ProSomnus Announces Significant Scientific, Technical, and Advocacy Updates
19/10/2026
World-Renowned Sleep Medicine Leaders Join ProSomnus Medical Advisory Board, RPMO₂ Enhancements, Published FLOSAT Study Results, and Scientific Contributions at CHEST 2026 SAN FRANCISCO, Oct. 19, 2026 (GLOBE NEWSWIRE [...]
Beacon Biosignals Partners with Project Sleep to Shorten the Path to Diagnosis for People with Idiopathic Hypersomnia and Narcolepsy
19/10/2026
The partnership connects Beacon's AI-driven neurotechnology with the patient-led advocacy community, expanding access to diagnosis and bringing patient voices directly into clinical research BOSTON, Oct. 19, 2026 (GLOBE [...]
Daré Bioscience Sponsors HERmedicine Educational Program for Clinicians on Managing Menopause After Breast Cancer
19/10/2026
Premier sponsorship of the HERmedicine and OncoMenopause Consortium ® program underscores Daré Bioscience's commitment to addressing unmet women’s health needs, including for women affected by breast cancer The program [...]
VIRBAC: Solid growth of +7.9% at CERS in YTD September 2026, fueled by double-digit growth of our Supercharge platforms
19/10/2026
End of September 2026 revenue reached €1,168 million : +7.9% at constant exchange rate and scope (at CERS) vs YTD September 2025 +5.9% at actual rates impacted by currency headwinds Balanced growth in both segments: [...]
VIRBAC: Solide croissance de +7,9 % à TCC à fin septembre 2026, portée par la croissance à deux chiffres de nos plateformes Supercharge
19/10/2026
Le chiffre d'affaires à fin septembre 2026 atteint 1 168 millions d'euros : +7,9 % à taux de change et périmètre constants (PCC) par rapport à fin septembre 2025 +5,9 % à taux réels, impacté par des effets de change [...]
Alignment Health Plan and Astrana Health Partner to Expand Access to Trusted Local Care for California Seniors
19/10/2026
New collaboration expands access to multilingual, community-based care across seven Northern and Southern California counties ORANGE, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning [...]
Strata Earns HFMA Peer Review Designation for 13 Consecutive Years
19/10/2026
Recognition reflects Strata’s commitment to delivering customer value and advancing healthcare financial decision-making CHICAGO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Strata Decision Technology today announced that after [...]
OneMedNet Signs Global Pharmaceutical Intelligence Provider as Channel Partner, Extending Reach in Pharma Market
19/10/2026
Agreement with a leading global provider of pharmaceutical intelligence and data solutions expands distribution of OneMedNet’s first-party, direct-from-source multimodal Real-World Data; Strengthening its presence in a [...]
SciSparc Shifts Focus to Agentic AI, Targeting Cybersecurity and Finance Applications
19/10/2026
TEL AVIV, Israel, Oct. 19, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), announced that it will shift its strategic focus toward Agentic AI-powered technologies, including [...]
Fangzhou and Cutia Therapeutics Partner to Advance AI-Powered Dermatology and Chronic Health Management
19/10/2026
GUANGZHOU, China, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, announced a strategic partnership with Cutia [...]
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Completion of Manufacturing Process Validation and Two-Year Stability of Preservative-Free Ketamine
19/10/2026
In advance of November 10, 2026 GDUFA goal date, three commercial lots of Preservative-Free Ketamine have been successfully manufactured in compliance with “Process Validation” required under FDA “Good Manufacturing [...]
Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026
19/10/2026
ROCKVILLE, Md., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Indivior to Report Third Quarter 2026 Financial Results
19/10/2026
RICHMOND, Va., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its third quarter 2026 financial results on Thursday, October 29, 2026. The results will [...]
Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026
19/10/2026
CAMBRIDGE, Mass., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]
J-Star Holding Co., Ltd. Advances U.S. Drone Manufacturing Initiative; Negotiates Acquisition of Facility in the Greater Houston Area
19/10/2026
Company is Organizing an Independent Texas-based Manufacturing Platform, Contributing Proprietary Composite Technology and Engineering Expertise to Support Planned U.S. Drone-Frame Production Strategic Real Estate [...]
Alpha Tau Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual Meeting
19/10/2026
- FDA approves IDE supplement expanding REGAIN from 10 to 20 patients, with additional study endpoints and interim analysis - - Abstract authored by REGAIN study principal investigator Dr. Joshua Palmer of The Ohio [...]
Dogwood Announces $5 Million Private Placement with CK Life Sciences Int’l., (Holdings) Inc.
19/10/2026
- Largest Shareholder Increases Position as Dogwood Advances Halneuron ® Toward Topline Phase 2b Data Readout in November 2026 - - Expected Proceeds from the Investment Enable Acceleration of Phase 3 Preparatory [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum